Piecing together the structure of retroviral integrase, an important target in AIDS therapy

被引:67
作者
Jaskolski, Mariusz [2 ,3 ]
Alexandratos, Jerry N. [1 ]
Bujacz, Grzegorz [3 ,4 ]
Wlodawer, Alexander [1 ]
机构
[1] NCI, Macromol Crystallog Lab, Frederick, MD 21702 USA
[2] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, Poznan, Poland
[3] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland
[4] Tech Univ Lodz, Inst Tech Biochem, PL-90924 Lodz, Poland
关键词
AIDS; antiretroviral drugs; DNA integration; HIV; integrase; SARCOMA-VIRUS INTEGRASE; DNA-BINDING DOMAIN; HIV-1; REVERSE-TRANSCRIPTASE; REFINED SOLUTION STRUCTURE; TERMINAL HHCC DOMAIN; ACTIVE-SITE BINDING; CATALYTIC DOMAIN; TYPE-1; INTEGRASE; CRYSTAL-STRUCTURE; VIRAL-DNA;
D O I
10.1111/j.1742-4658.2009.07009.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integrase ( IN) is one of only three enzymes encoded in the genomes of all retroviruses, and is the one least characterized in structural terms. IN catalyzes processing of the ends of a DNA copy of the retroviral genome and its concerted insertion into the chromosome of the host cell. The protein consists of three domains, the central catalytic core domain flanked by the N-terminal and C-terminal domains, the latter being involved in DNA binding. Although the Protein Data Bank contains a number of NMR structures of the N-terminal and C-terminal domains of HIV-1 and HIV-2, simian immunodeficiency virus and avian sarcoma virus IN, as well as X-ray structures of the core domain of HIV-1, avian sarcoma virus and foamy virus IN, plus several models of two-domain constructs, no structure of the complete molecule of retroviral IN has been solved to date. Although no experimental structures of IN complexed with the DNA substrates are at hand, the catalytic mechanism of IN is well understood by analogy with other nucleotidyl transferases, and a variety of models of the oligomeric integration complexes have been proposed. In this review, we present the current state of knowledge resulting from structural studies of IN from several retroviruses. We also attempt to reconcile the differences between the reported structures, and discuss the relationship between the structure and function of this enzyme, which is an important, although so far rather poorly exploited, target for designing drugs against HIV-1 infection.
引用
收藏
页码:2926 / 2946
页数:21
相关论文
共 109 条
[71]  
Lutzke Ramon A. Puras, 1997, Genes and Function, V1, P289
[72]   IDENTIFICATION OF A HEXAPEPTIDE INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE PROTEIN BY USING A COMBINATORIAL CHEMICAL LIBRARY [J].
LUTZKE, RAP ;
EPPENS, NA ;
WEBER, PA ;
HOUGHTEN, RA ;
PLASTERK, RHA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (25) :11456-11460
[73]   Structure-based mutational analysis of the C-terminal DNA-Binding domain of human immunodeficiency virus type 1 integrase: Critical residues for protein oligomerization and DNA binding [J].
Lutzke, RAP ;
Plasterk, RHA .
JOURNAL OF VIROLOGY, 1998, 72 (06) :4841-4848
[74]   LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells [J].
Maertens, G ;
Cherepanov, P ;
Pluymers, W ;
Busschots, K ;
De Clercq, E ;
Debyser, Z ;
Engelborghs, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) :33528-33539
[75]   Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor:: High level of similarity of the active site with other viral integrases [J].
Maignan, S ;
Guilloteau, JP ;
Zhou-Liu, Q ;
Clément-Mella, C ;
Mikol, V .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 282 (02) :359-368
[76]   Designing HIV integrase inhibitors-shooting the last arrow [J].
Makhija, Mahindra T. .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (20) :2429-2441
[77]   Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants [J].
Marinello, Jessica ;
Marchand, Christophe ;
Mott, Bryan T. ;
Bain, Anjali ;
Thomas, Craig J. ;
Pommier, Yves .
BIOCHEMISTRY, 2008, 47 (36) :9345-9354
[78]   Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers [J].
Maroun, RG ;
Gayet, S ;
Benleulmi, MS ;
Porumb, H ;
Zargarian, L ;
Merad, H ;
Leh, H ;
Mouscadet, JF ;
Troalen, FR ;
Fermandjian, S .
BIOCHEMISTRY, 2001, 40 (46) :13840-13848
[79]   Inhibitors of HIV-1 protease: Current state of the art 10 years after their introduction. from Antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors [J].
Mastrolorenzo, Antonio ;
Rusconi, Stefano ;
Scozzafava, Andrea ;
Barbaro, Giuseppe ;
Supuran, Claudiu T. .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (26) :2734-2748
[80]   Effect of HIV integrase inhibitors on the RAG1/2 recombinase [J].
Melek, M ;
Jones, JM ;
O'Dea, MH ;
Pais, G ;
Burke, TR ;
Pommier, Y ;
Neamati, N ;
Gellert, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :134-137